Coordination of care for patients diagnosed with acute myeloid leukemia, particularly those who are ineligible for transplant, can impact access to specialist care, clinical trials, and cancer programs with advanced capabilities to treat patients.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
Coordination of care for patients diagnosed with acute myeloid leukemia, particularly those who are ineligible for transplant, can impact access to specialist care, clinical trials, and cancer programs with advanced capabilities to treat patients with acute myeloid leukemia. In this episode, CANCER BUZZ speaks with Geoffrey Uy, MD, professor of Bone Marrow Transplantation and Leukemia at Washington University’s School of Medicine in St. Louis, Missouri and Khoan Tuong Vu, MD, hematologist oncologist at Texas Oncology, who share strategies and best practices for co-managing care for patients with acute myeloid leukemia.
Geoffrey L. Uy, MD
Professor of Medicine, Bone Marrow Transplantation & Leukemia\
Division of Oncology
Washington University School of Medicine
St. Louis, MO
Khoan Tuong Vu, MD
Hematologist Oncologist
Texas Oncology
Dallas, TX
“The impact of care coordination can be tremendous. A large proportion of our patients come from several hours away. Through care coordination and through things like telehealth, we can deliver high quality care to patients in their [own] community.” – Geoffrey L. Uy, MD
“Successful care coordination is a seamless transition of care where we work together as a cohesive team, even across different cancer centers, with a consistent message and consistent treatment plan.” – Khoan Tuong Vu, MD
This is the third episode of a four-part series developed in connection with the ACCC education program Achieving and Maintaining Better Outcomes for Patients with Acute Myeloid Leukemia. This episode was made possible with support by Bristol Myers-Squibb.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
June 30, 2026
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
